HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen J Russell Selected Research

Oncolytic Virotherapy

1/2022Evaluation of the stability and intratumoral delivery of foreign transgenes encoded by an oncolytic Foamy Virus vector.
3/2021Oncolytic Foamy Virus - generation and properties of a nonpathogenic replicating retroviral vector system that targets chronically proliferating cancer cells.
1/2021MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.
1/2021The long-lasting enigma of polycytidine (polyC) tract.
12/2020Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma.
9/2020Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers.
12/2019Dual-Isotope SPECT Imaging with NIS Reporter Gene and Duramycin to Visualize Tumor Susceptibility to Oncolytic Virus Infection.
1/2018Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer.
12/2016Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model.
4/2016MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen J Russell Research Topics

Disease

113Neoplasms (Cancer)
01/2022 - 02/2002
48Multiple Myeloma
01/2021 - 12/2002
28Vesicular Stomatitis
01/2022 - 12/2002
24Measles
01/2021 - 05/2002
24Infections
01/2021 - 11/2003
19Immunoglobulin Light-chain Amyloidosis
01/2021 - 04/2006
11Ovarian Neoplasms (Ovarian Cancer)
01/2018 - 08/2002
10Virus Diseases (Viral Diseases)
06/2021 - 03/2006
10Breast Neoplasms (Breast Cancer)
01/2018 - 06/2006
9Amyloidosis
01/2018 - 10/2010
9Glioma (Gliomas)
01/2018 - 10/2004
7Glioblastoma (Glioblastoma Multiforme)
01/2018 - 05/2003
6Wounds and Injuries (Trauma)
04/2020 - 01/2015
5Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 08/2002
5Hepatocellular Carcinoma (Hepatoma)
09/2020 - 12/2006
4Plasmacytoma
12/2021 - 07/2014
4POEMS Syndrome (Syndrome, POEMS)
01/2016 - 11/2008
4Prostatic Neoplasms (Prostate Cancer)
12/2009 - 11/2005
3Inflammation (Inflammations)
01/2022 - 08/2017
3Pancreatic Neoplasms (Pancreatic Cancer)
09/2020 - 01/2009
3Mesothelioma
01/2018 - 01/2010
3Paraproteinemias (Monoclonal Gammopathy)
05/2016 - 10/2011
3Neoplasm Metastasis (Metastasis)
07/2010 - 06/2006
3Bone Diseases (Bone Disease)
07/2010 - 04/2004
2Cytokine Release Syndrome
01/2021 - 01/2016
2Thyroid Neoplasms (Thyroid Cancer)
01/2018 - 10/2017
2Melanoma (Melanoma, Malignant)
01/2017 - 07/2012
2Lymphopenia (Lymphocytopenia)
12/2016 - 01/2016
2Smoldering Multiple Myeloma
05/2016 - 10/2010
2Lymphoma (Lymphomas)
01/2016 - 01/2007
2Thrombocytopenia (Thrombopenia)
01/2016 - 01/2007

Drug/Important Bio-Agent (IBA)

26sodium-iodide symporter (sodium iodide symporter)IBA
01/2022 - 12/2003
24VaccinesIBA
01/2021 - 08/2002
24Proteins (Proteins, Gene)FDA Link
10/2020 - 03/2004
15Glycoproteins (Glycoprotein)IBA
01/2022 - 04/2003
12InterferonsIBA
01/2022 - 12/2002
12AntibodiesIBA
01/2021 - 06/2006
11Dexamethasone (Maxidex)FDA LinkGeneric
11/2017 - 01/2007
10Lenalidomide (CC 5013)FDA Link
11/2017 - 01/2007
9Hemagglutinins (Hemagglutinin)IBA
09/2020 - 03/2004
9Antiviral Agents (Antivirals)IBA
09/2020 - 09/2006
8Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2006
8IodidesIBA
01/2018 - 07/2003
8Carcinoembryonic AntigenIBA
01/2018 - 05/2003
7Pharmaceutical PreparationsIBA
01/2022 - 12/2002
6Neutralizing AntibodiesIBA
01/2022 - 01/2007
6AntigensIBA
12/2020 - 07/2009
6Antineoplastic Agents (Antineoplastics)IBA
03/2012 - 08/2002
6Peptides (Polypeptides)IBA
02/2010 - 05/2002
5MicroRNAs (MicroRNA)IBA
12/2021 - 11/2008
5Neoplasm Antigens (Tumor Antigens)IBA
12/2020 - 10/2013
5Membrane Glycoproteins (Membrane Glycoprotein)IBA
10/2020 - 10/2004
5Biological ProductsIBA
04/2020 - 10/2004
5pomalidomideIBA
11/2017 - 10/2009
5Bortezomib (Velcade)FDA Link
11/2017 - 07/2005
4Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2021 - 06/2012
4CytokinesIBA
10/2019 - 09/2009
4Matrix Metalloproteinases (MMPs)IBA
06/2018 - 11/2004
4Interferon-betaIBA
01/2017 - 11/2003
4LigandsIBA
12/2013 - 11/2004
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2012 - 11/2010
4Green Fluorescent ProteinsIBA
05/2012 - 12/2006
4Immunoglobulins (Immunoglobulin)IBA
10/2010 - 04/2006
4ErbB Receptors (EGF Receptor)IBA
04/2007 - 03/2004
3atelocollagenIBA
01/2022 - 12/2016
3Messenger RNA (mRNA)IBA
01/2022 - 01/2010
3IsotopesIBA
12/2019 - 07/2003
3CollagenIBA
06/2018 - 01/2015
3HydrogelsIBA
01/2018 - 01/2015
3Radioisotopes (Radionuclides)IBA
01/2016 - 12/2004
3Brain Natriuretic Peptide (Natrecor)FDA Link
06/2015 - 03/2011
3pro-brain natriuretic peptide (1-76)IBA
06/2015 - 10/2010
3echistatinIBA
12/2013 - 06/2005
3Thalidomide (Thalomid)FDA Link
10/2010 - 10/2009
3Attenuated VaccinesIBA
07/2009 - 07/2005
3epidermal growth factor receptor VIIIIBA
04/2007 - 02/2005
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2016
2LuciferasesIBA
01/2021 - 01/2020
2Immune Checkpoint InhibitorsIBA
12/2020 - 10/2019
2RNA (Ribonucleic Acid)IBA
09/2020 - 06/2011
2Anti-Bacterial Agents (Antibiotics)IBA
04/2020 - 08/2017
2Immune Sera (Antisera)IBA
01/2019 - 06/2010
2Melphalan (Alkeran)FDA LinkGeneric
01/2018 - 01/2016
2OsteoprotegerinIBA
11/2017 - 04/2004
2Pyruvaldehyde (Methylglyoxal)IBA
08/2017 - 03/2015
2talimogene laherparepvecIBA
01/2017 - 07/2012
2Peptide Hydrolases (Proteases)FDA Link
12/2016 - 06/2006
2CreatinineIBA
11/2016 - 06/2013
2fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA
01/2016 - 04/2015

Therapy/Procedure

88Therapeutics
01/2022 - 05/2002
25Oncolytic Virotherapy
01/2022 - 12/2002
9Stem Cell Transplantation
01/2020 - 12/2002
9Radiotherapy
08/2017 - 07/2003
5Intravenous Administration
01/2016 - 11/2003
4Drug Therapy (Chemotherapy)
01/2018 - 02/2008
3Immunotherapy
10/2019 - 01/2016
3Euthanasia (Mercy Killing)
12/2016 - 06/2011
3Injections
10/2015 - 01/2007
2Aftercare (After-Treatment)
01/2021 - 01/2015
2Hematopoietic Stem Cell Transplantation
01/2019 - 01/2019